Investing.com -- GoodRx (NASDAQ: GDRX) stock surged 18% after announcing a collaboration with Novo Nordisk (NYSE: NVO) to offer Ozempic and Wegovy to eligible self-paying patients for $499 per month.

Novo Nordisk shares (DK:NOVO.B) (NVO) rose 5% in opening New York trade. The American depository receipts however have plunged 37% this year amid increased competition for its weight-loss drugs as ...

As they continue to make strides in Bigg Boss Malayalam Season 7, a particular incident has caught the attention of viewers, wherein Adhila Nasarin talked about how she fell in love with Fathima Noora ...

Potato salad, a signature summer dish, is defined by its maker. My grandmother’s salad was substantially swathed in mayo, ...

The vehicle belonging to a Sacramento woman who went missing with her baby last month has been found submerged in a central California canal, and the body of an adult and infant were found inside, ...

Speak to your aunt privately and tell her you want to make an uncomfortable observation. With her blessing, tell her what you ...

Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC ...

Trump’s problem with Zelensky is personal but, as World Affairs Editor Sam Kiley explains, he may finally understand that ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...